SYNNOVATION THERAPEUTICS
Live / Allowed — Notice of allowance issued (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99337006
- Mark type
- Stylized text
- Filed
- 14 Aug 2025
- Published for opposition
- 27 Jan 2026
- Attorney of record
- Susan Neuberger Weller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer
- Class 042 — Scientific and technological services: Research and development of pharmaceutical preparations for treatment of cancer; conducting clinical trials for others in the field of drug development for the treatment of cancer; pharmaceutical drug development services focusing on small molecule targeted therapies for the treatment of cancer
Owner
- Synnovation Therapeutics, LLC, Wilmington, DE, US
- Synnovation Therapeutics, LLC, Wilmington, DE, US
Prosecution history
- 24 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Jan 2026 — PUBLISHED FOR OPPOSITION
- 21 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Dec 2025 — ASSIGNED TO EXAMINER
- 29 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 14 Aug 2025 — NEW APPLICATION ENTERED